NEW YORK — Johnson & Johnson has agreed to pay $230 million to settle an opioid lawsuit from the State of New York.

The state attorney general announced the settlement Saturday.

The money J&J has to cough up will go toward prevention and treatment of opioid addiction.

Johnson & Johnson also won’t be allowed to make or sell opioids in New York.

A company spokesperson says it decided last year, to stop selling pain medications in the U.S.

In 2019, New York’s AG filed a lawsuit claiming Johnson and Johnson, along with other pharmaceutical companies, engaged in deceptive marketing and did not do enough to prevent opioids form falling into the wrong hands.

J & J has been hit hard by opioid-related lawsuits, including a $572 million verdict in Oklahoma and an ongoing case in California.